Developer docs
API playgroundTry for free, no card

Search company profiles

neoLaser

Full company profile

uuid000gqcf

Namestring
neoLaser
Legal namestring
G.N.S neoLaser Ltd.
Websiteurl
neo-laser.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

neoLaser (legal name G.N.S. neoLaser Ltd.) is an Israeli medical device company founded in 2012 in Caesarea that designs, manufactures, and distributes surgical diode laser systems and proprietary fiber/probe consumables. Its flagship neoV platform comprises four wavelength-specific laser systems — neoV1940, neoV1470, neoV1064, and neoV980 — optimized for distinct clinical applications including endovenous laser ablation (EVLA), proctology (hemorrhoids, fistula, pilonidal sinus), percutaneous laser disc decompression (PLDD), podiatry, and aesthetic vascular procedures. The company's core technical differentiation is its proprietary CORONA fiber technology family (including CORONA 360, CORONA Infinite Ring, and RIGID probes), which uses patented multi-ring cylindrical emission patterns and fused quartz tips to deliver precise thermal energy with reduced collateral damage. The systems are marketed as the world's smallest high-power surgical lasers due to proprietary cooling technology.

neoLaser generates revenue through two primary streams: (1) capital equipment sales of neoV laser systems, and (2) recurring sales of proprietary fiber and probe consumables designed exclusively for neoV hardware. Pricing is quote-based and not publicly disclosed, with sales executed exclusively through a global network of authorized distributors and dealers. The company holds EN ISO13485:2021 certification and regulatory registrations across FDA (USA), CE Mark (Europe), Canada, Brazil, Australia, Israel, and Taiwan. With 2,300+ systems placed across 50+ countries and 500,000+ procedures performed, neoLaser serves hospitals, surgical centers, and clinics across vascular surgery, colorectal surgery, spine surgery, podiatry, and aesthetic specialties. In August 2024, the company was acquired by investment firm Afinum 9 as part of the formation of the MedTech Laser Group alongside A.R.C. Laser GmbH, with the founders of both companies co-investing; neoLaser continues to operate independently while leveraging combined R&D, sales, marketing, and regulatory capabilities within the group.

Short descriptiontext

neoLaser is an Israeli medical device company that designs, manufactures, and distributes surgical diode laser systems and proprietary fiber consumables (neoV platform) for endovenous, proctology, spine, podiatry, and aesthetic procedures, serving hospitals and clinics across 50+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCaesarea, Israel
HQ citystring
Caesarea
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
surgical laser systems, endovenous laser ablation, medical diode lasers, proctology laser probes, percutaneous laser disc decompression
Industry2 codes
PRIMARYHLAHADAC
Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAM
Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Surgical Laser Systems
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Surgical Laser Systems Sales
TypeHardware Sales
Description

neoLaser designs, engineers, and manufactures surgical laser systems and proprietary fiber/probe technology. Revenue is generated through the sale of laser hardware systems (neoV1940, neoV1470, neoV1064, neoV980) along with compatible fiber and probe accessories.

neo-laser.com
2Consumables and Accessories
TypeHardware Sales
Description

Sale of proprietary fiber products including CORONA Infinite Ring Fibers, CORONA 360 Fibers, hemorrhoid probes, fistula probes, and procedure kits (PLDD Kit, EVLA Introducer Kit, Hemorrhoid Cannula, Focusing Hand Pieces).

neo-laser.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Quote-based pricing through distributor network
ModelOtherBilling cadenceMulti-year contract
Notes

No pricing is listed publicly. The website directs interested parties to contact neoLaser or their local distributor for pricing information on laser systems and fibers.

neo-laser.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1neoV Platform
Description

Surgical laser platform family including neoV1940, neoV1470, neoV1064, and neoV980 laser systems for EVLA, proctology, PLDD, and aesthetic procedures.

neo-laser.com
+2 more records
Core offering1 text field

neoLaser designs, engineers, and manufactures surgical diode laser systems and proprietary fiber/probe accessories for minimally invasive medical procedures. Its flagship neoV platform encompasses four wavelength-specific laser systems (neoV1940, neoV1470, neoV1064, neoV980) used for endovenous laser ablation (EVLA), proctology (hemorrhoids, fistula, pilonidal sinus), percutaneous laser disc decompression (PLDD), podiatry, and aesthetic vascular treatments. The company sells these systems and consumable CORONA fiber/probe products to hospitals, surgical centers, and clinics through a global distributor network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 14 values shown
  • Higher closure rates vs RFA for both truncal and perforator veins (KR. Woodburn, 2020)
+13 more records
Product overview1 text field

neoLaser is a surgical laser manufacturer offering the neoV platform as its core product line, comprising four distinct laser systems (neoV1940, neoV1470, neoV1064, and neoV980) designed for different medical specialties including EVLA (endovenous laser ablation), proctology, PLDD (percutaneous laser disc decompression), and podiatry. The platform is complemented by an extensive portfolio of proprietary CORONA fiber and probe products featuring proprietary multiple ring emission technology, including EVLA fibers (Infinite Ring Fiber, CORONA 360 Slim Fiber), hemorrhoid probes (RIGID Infinite Ring, CORONA Infinite Ring, CORONA Hemorrhoid), and fistula probes (Infinite Ring Fistula, CORONA Fistula). Supporting accessories include PLDD kits, EVLA introducer kits, hemorrhoid cannulas, and focusing hand pieces. All products are designed, engineered, and manufactured with EN ISO13485:2021 certification and are registered with regulatory bodies including FDA, CE Mark, Canada, Brazil, Australia, Israel, Taiwan, and more.

Product and service3 records
1neoV1940 Laser System
CategoryCore Product - Surgical Laser System
Description

Next generation 1940nm surgical diode laser system representing the most advanced platform for endovenous laser ablation (EVLA), providing penetration depth below 1mm for contained thermal damage within the vein wall, preventing collateral damage while maintaining long-term closure rates. Targeted at vascular surgeons and hospitals performing minimally invasive vein treatment.

2neoV1470 Laser System
CategoryCore Product - Surgical Laser System
Description

Workhorse 1470nm surgical diode laser platform representing the large majority of the installed base. Microsurgical instrument for endovenous laser ablation of veins and key indications in proctology and PLDD, with peak water absorption at 1470nm enabling precise cutting with good coagulation of soft tissue.

3neoV1064 Laser System
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-08-06
Description

German laser company that was acquired alongside neoLaser as part of the MedTech Laser Group formation. The two companies will operate independently while leveraging combined R&D, sales, marketing, and regulatory capabilities, capitalizing on growth trends in the global ophthalmologic and surgical laser market.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

neoLaser

Surgical Laser Systemsneo-laser.com

neoLaser is an Israeli medical device company that designs, manufactures, and distributes surgical diode laser systems and proprietary fiber consumables (neoV platform) for endovenous, proctology, spine, podiatry, and aesthetic procedures, serving hospitals and clinics across 50+ countries.

What neoLaser does

neoLaser (legal name G.N.S. neoLaser Ltd.) is an Israeli medical device company founded in 2012 in Caesarea that designs, manufactures, and distributes surgical diode laser systems and proprietary fiber/probe consumables. Its flagship neoV platform comprises four wavelength-specific laser systems — neoV1940, neoV1470, neoV1064, and neoV980 — optimized for distinct clinical applications including endovenous laser ablation (EVLA), proctology (hemorrhoids, fistula, pilonidal sinus), percutaneous laser disc decompression (PLDD), podiatry, and aesthetic vascular procedures. The company's core technical differentiation is its proprietary CORONA fiber technology family (including CORONA 360, CORONA Infinite Ring, and RIGID probes), which uses patented multi-ring cylindrical emission patterns and fused quartz tips to deliver precise thermal energy with reduced collateral damage. The systems are marketed as the world's smallest high-power surgical lasers due to proprietary cooling technology.

neoLaser generates revenue through two primary streams: (1) capital equipment sales of neoV laser systems, and (2) recurring sales of proprietary fiber and probe consumables designed exclusively for neoV hardware. Pricing is quote-based and not publicly disclosed, with sales executed exclusively through a global network of authorized distributors and dealers. The company holds EN ISO13485:2021 certification and regulatory registrations across FDA (USA), CE Mark (Europe), Canada, Brazil, Australia, Israel, and Taiwan. With 2,300+ systems placed across 50+ countries and 500,000+ procedures performed, neoLaser serves hospitals, surgical centers, and clinics across vascular surgery, colorectal surgery, spine surgery, podiatry, and aesthetic specialties. In August 2024, the company was acquired by investment firm Afinum 9 as part of the formation of the MedTech Laser Group alongside A.R.C. Laser GmbH, with the founders of both companies co-investing; neoLaser continues to operate independently while leveraging combined R&D, sales, marketing, and regulatory capabilities within the group.

neoLaser firmographics

Firmographics
Name
neoLaser
Legal name
G.N.S neoLaser Ltd.
Website
https://neo-laser.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
neoLaser is an Israeli medical device company that designs, manufactures, and distributes surgical diode laser systems and proprietary fiber consumables (neoV platform) for endovenous, proctology, spine, podiatry, and aesthetic procedures, serving hospitals and clinics across 50+ countries.
Ownership category
akta.pro rank

neoLaser industry classification

Industry
Product category
Surgical Laser Systems
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAC
Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAM
Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Surgical laser systems
  • Endovenous laser ablation
  • Medical diode lasers
  • Proctology laser probes
  • Percutaneous laser disc decompression

Where neoLaser is headquartered

Location

Headquarters

HQ city
Caesarea
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

neoLaser business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Surgical Laser Systems Sales: neoLaser designs, engineers, and manufactures surgical laser systems and proprietary fiber/probe technology. Revenue is generated through the sale of laser hardware systems (neoV1940, neoV1470, neoV1064, neoV980) along with compatible fiber and probe accessories.
  2. Consumables and Accessories: Sale of proprietary fiber products including CORONA Infinite Ring Fibers, CORONA 360 Fibers, hemorrhoid probes, fistula probes, and procedure kits (PLDD Kit, EVLA Introducer Kit, Hemorrhoid Cannula, Focusing Hand Pieces).

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based pricing through distributor network

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

neoLaser product offering

Product offering

Core offering

neoLaser designs, engineers, and manufactures surgical diode laser systems and proprietary fiber/probe accessories for minimally invasive medical procedures. Its flagship neoV platform encompasses four wavelength-specific laser systems (neoV1940, neoV1470, neoV1064, neoV980) used for endovenous laser ablation (EVLA), proctology (hemorrhoids, fistula, pilonidal sinus), percutaneous laser disc decompression (PLDD), podiatry, and aesthetic vascular treatments. The company sells these systems and consumable CORONA fiber/probe products to hospitals, surgical centers, and clinics through a global distributor network.

Product overview

neoLaser is a surgical laser manufacturer offering the neoV platform as its core product line, comprising four distinct laser systems (neoV1940, neoV1470, neoV1064, and neoV980) designed for different medical specialties including EVLA (endovenous laser ablation), proctology, PLDD (percutaneous laser disc decompression), and podiatry. The platform is complemented by an extensive portfolio of proprietary CORONA fiber and probe products featuring proprietary multiple ring emission technology, including EVLA fibers (Infinite Ring Fiber, CORONA 360 Slim Fiber), hemorrhoid probes (RIGID Infinite Ring, CORONA Infinite Ring, CORONA Hemorrhoid), and fistula probes (Infinite Ring Fistula, CORONA Fistula). Supporting accessories include PLDD kits, EVLA introducer kits, hemorrhoid cannulas, and focusing hand pieces. All products are designed, engineered, and manufactured with EN ISO13485:2021 certification and are registered with regulatory bodies including FDA, CE Mark, Canada, Brazil, Australia, Israel, Taiwan, and more.

Differentiator

Problem solved

Functional benefit

Brands

  • neoV Platform: Surgical laser platform family including neoV1940, neoV1470, neoV1064, and neoV980 laser systems for EVLA, proctology, PLDD, and aesthetic procedures.
  • CORONA Fiber Technology
  • MedTech Laser Group

Products and services

  • neoV1940 Laser System Next generation 1940nm surgical diode laser system representing the most advanced platform for endovenous laser ablation (EVLA), providing penetration depth below 1mm for contained thermal damage within the vein wall, preventing collateral damage while maintaining long-term closure rates. Targeted at vascular surgeons and hospitals performing minimally invasive vein treatment.
  • neoV1470 Laser System Workhorse 1470nm surgical diode laser platform representing the large majority of the installed base. Microsurgical instrument for endovenous laser ablation of veins and key indications in proctology and PLDD, with peak water absorption at 1470nm enabling precise cutting with good coagulation of soft tissue.
  • neoV1064 Laser System

Quantifiable outcome

  • Higher closure rates vs RFA for both truncal and perforator veins (KR. Woodburn, 2020)
  • +13 more outcomes

Companies that use neoLaser

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles4 records

neoLaser technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

neoLaser partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • A.R.C. Laser GmbHcoreStrategic or Co-development Partner · 6 August 2024German laser company that was acquired alongside neoLaser as part of the MedTech Laser Group formation. The two companies will operate independently while leveraging combined R&D, sales, marketing, and regulatory capabilities, capitalizing on growth trends in the global ophthalmologic and surgical laser market.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

neoLaser competitors and assessment

Company assessment

Market position

Strengths4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

neoLaser social profiles

Digital presence

neoLaser compliance and trust

Trust signal

Compliance4 records

neoLaser financial estimates

Financial estimate

Revenue estimate

Valuation estimate

neoLaser leadership team

Management profile

Number of profiles

Profiles6 records

neoLaser funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

neoLaser M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about neoLaser

What does neoLaser do?

neoLaser designs, engineers, and manufactures surgical diode laser systems and proprietary fiber/probe accessories for minimally invasive medical procedures. Its flagship neoV platform encompasses four wavelength-specific laser systems (neoV1940, neoV1470, neoV1064, neoV980) used for endovenous laser ablation (EVLA), proctology (hemorrhoids, fistula, pilonidal sinus), percutaneous laser disc decompression (PLDD), podiatry, and aesthetic vascular treatments. The company sells these systems and consumable CORONA fiber/probe products to hospitals, surgical centers, and clinics through a global distributor network.

Is neoLaser a public or private company?

neoLaser is a private company. It is classified as private equity controlled and is currently operating.

When was neoLaser founded?

neoLaser was founded in 2012. It employs 11 to 50 people.

Where is neoLaser based?

neoLaser is headquartered in Caesarea, Israel, in the Middle East region.

How does neoLaser make money?

Two revenue lines are on record. Surgical Laser Systems Sales are the primary driver. The others are consumables and Accessories.

Does neoLaser have an API?

No public API is recorded for neoLaser.

What industry is neoLaser in?

neoLaser's product category is Surgical Laser Systems. Its primary akta.pro industry code is HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser), with a secondary code of HLAHADAM, Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales